Literature DB >> 17328851

[Genital ulcers caused by sexually transmitted diseases: current therapies, diagnosis and their relevance in HIV pandemy].

João Borges Da Costa1, Dulce Domingues, R Castro, Filomena Exposto.   

Abstract

The sexual transmitted pathogens associated with genital ulcers are Treponema pallidum, Haemophilus ducreyi, Calymmatobacterium granulomatis, Chlamydia trachomatis and Herpes simplex virus type 1 or 2. Although geographic differences still exist, herpetic infections prevalence is growing worldwide as the most frequent ulcerative sexual transmitted disease. The failure of the many different used guidelines in achieving a sustained reduction in the number of new cases, in particular the WHO syndromic management, leads into an over treatment of bacterial agents and missing of viral agents. This situation is also associated with poor efficacy and wasting of economical resources. Ulcerative and non-ulcerative sexual transmitted diseases are important in the world HIV pandemy because they promote HIV transmission and are also associated with the disease evolution. Portugal had until recently the highest incidence of HIV infection in Europe and that points out to importance of treating and control of both ulcerative and non-ulcerative sexual transmitted diseases in order.

Entities:  

Mesh:

Year:  2007        PMID: 17328851

Source DB:  PubMed          Journal:  Acta Med Port        ISSN: 0870-399X


  3 in total

1.  Skin Diseases in the Era of Highly Active Antiretroviral Therapy: A Retrospective Study of 534 Patients.

Authors:  Jennifer Tan; Ana Pina; João Borges-Costa
Journal:  J Int Assoc Provid AIDS Care       Date:  2018 Jan-Dec

2.  Genital Ulcer Disease: How Worrisome Is It Today? A Status Report from New Delhi, India.

Authors:  Sumathi Muralidhar; Richa Talwar; Deepa Anil Kumar; Joginder Kumar; Manju Bala; Nilofar Khan; V Ramesh
Journal:  J Sex Transm Dis       Date:  2013-04-03

3.  Donovanosis.

Authors:  Walter Belda Junior
Journal:  An Bras Dermatol       Date:  2020-09-17       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.